Cargando…
COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect
Patients with neurological symptoms should be enquired about recent vaccination history. It is important after the COVID‐19 mRNA vaccine, which is newly introduced as it might link to the development of a wider variety of neurological diseases.
Autores principales: | Matarneh, Ahmad S., Al‐battah, Alia Hani, Farooqui, Khalid, Ghamoodi, Mohamed, Alhatou, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405530/ https://www.ncbi.nlm.nih.gov/pubmed/34484780 http://dx.doi.org/10.1002/ccr3.4756 |
Ejemplares similares
-
Atypical Guillain–Barre syndrome with T6 sensory level
por: Al‐Ameen, Osamah, et al.
Publicado: (2022) -
Lesion Localization and Prognosis Using Electrodiagnostic Studies in Facial Diplegia: A Rare Variant of Guillain-Barre Syndrome
por: Ali, Liaquat, et al.
Publicado: (2022) -
Guillain Barre Syndrome: A Rare Cause of Floppy Neonate
por: Meshram, Rajkumar M., et al.
Publicado: (2020) -
A young man with Guillain–Barré syndrome, with a stroke-like presentation and physical findings suggestive of cervical myelopathy
por: Siddiqi, Maria, et al.
Publicado: (2023) -
Rare occurrence of Guillain-Barré syndrome after Moderna vaccine
por: Bijoy George, Tissa, et al.
Publicado: (2022)